These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 7184270)

  • 1. [Liver lesions in hereditary and experimental erythropoietic protoporphyria].
    Alexandrakis E; Klinge O
    Verh Dtsch Ges Pathol; 1982; 66():430-6. PubMed ID: 7184270
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of protoporphyrins in erythropoietic protoporphyria and griseofulvin-induced murine protoporphyria. Binding affinities, distribution, and fluorescence spectra in various blood fractions.
    Poh-Fitzpatrick MB; Lamola AA
    J Clin Invest; 1977 Aug; 60(2):380-9. PubMed ID: 874098
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Erythropoietic protoporphyria. III. Experimental studies of model systems: Pathogenesis of liver damage].
    Hönigsmann H
    Z Hautkr; 1977 Jun; 52(11):599-621. PubMed ID: 196420
    [No Abstract]   [Full Text] [Related]  

  • 4. [Experimental protoporphyria induced by griseofulvin. II. Effects of cholic acid ingestion in griseofulvin-induced protoporphyria mice].
    Irifune H
    Nihon Hifuka Gakkai Zasshi; 1988 Nov; 98(12):1177-82. PubMed ID: 3230643
    [No Abstract]   [Full Text] [Related]  

  • 5. Experimental murine protoporphyria induced by griseofulvin (GF): the relationship between hepatic porphyrin levels and liver function test values in mice treated with GF.
    Tanaka K; Ohgami T; Nonaka S
    J Dermatol; 1993 Sep; 20(9):545-53. PubMed ID: 8227709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse model for protoporphyria. III. Experimental production of chronic erythropoietic protoporphyria-like skin lesions.
    Hönigsmann H; Gschnait F; Konrad K; Stingi G; Wolff K
    J Invest Dermatol; 1976 Mar; 66(3):188-95. PubMed ID: 1249448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Griseofulvin-induced protoporphyria revisited.
    Gederaas OA; Brekke OL; Romslo I
    Photodermatol Photoimmunol Photomed; 1990 Apr; 7(2):82-5. PubMed ID: 2400679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Erythropoietic protoporphyria. I. Clinical aspects and problems of pathogenesis].
    Hönigsmann H
    Z Hautkr; 1977 May; 52(9):495-509. PubMed ID: 868203
    [No Abstract]   [Full Text] [Related]  

  • 9. A light and electron microscopic study of the liver in case of erythrohepatic protoporphyria and in griseofulvin-induced porphyria in mice.
    Matilla A; Molland EA
    J Clin Pathol; 1974 Sep; 27(9):698-709. PubMed ID: 4372253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse model for protoporphyria. I. The liver and hepatic protoporphyrin crystals.
    Gschnait F; Konrad K; Hönigsmann H; Denk H; Wolff K
    J Invest Dermatol; 1975 Sep; 65(3):290-9. PubMed ID: 1159316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reversibility of griseofulvin induced protoporphyria in the mice].
    Irifune H
    Nihon Hifuka Gakkai Zasshi; 1987 Jun; 97(7):801-4. PubMed ID: 3669397
    [No Abstract]   [Full Text] [Related]  

  • 12. Cholic acid amelioration of light and electron microscopic hepatic lesions in experimental protoporphyria.
    Lefkowitch JH; Feng-Chen KC; Sklar JA; Poh-Fitzpatrick MB
    Hepatology; 1983; 3(3):399-406. PubMed ID: 6840685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Liver cirrhosis in erythropoetic protoporphyria: erythrohepatic protoporphyria].
    Doss M; Keller J; Hornstein OP; Pfeifer U; Altmann HW; Schulze-Bonsel H; Welsch A; von Hinüber G
    Internist (Berl); 1985 Jul; 26(7):441-5. PubMed ID: 3897113
    [No Abstract]   [Full Text] [Related]  

  • 14. Griseofulvin causing hyperhemopexinemia and hepatic proliferation in mice: an in vivo and in vitro study.
    Cripps DJ; Liem HH; Muller-Eberhard U
    J Invest Dermatol; 1977 Feb; 68(2):82-7. PubMed ID: 833440
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The histopathology and ultrastructure of liver disease in erythropoietic protoporphyria.
    MacDonald DM; Germain D; Perrot H
    Br J Dermatol; 1981 Jan; 104(1):7-17. PubMed ID: 7459272
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The influence of ursodesoxycholic acid (URSO) on griseofulvin (GF)-induced protoporphyria].
    Irifune H; Tsukazaki N; Watanabe M; Nonaka S
    Nihon Hifuka Gakkai Zasshi; 1991 Jul; 101(8):813-7. PubMed ID: 1942584
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Erythropoietic protoporphyria].
    Karalitskiĭ EM; Bumbak FV; Roshka GA
    Vestn Dermatol Venerol; 1986; (7):55-8. PubMed ID: 3765812
    [No Abstract]   [Full Text] [Related]  

  • 18. Relationship between N-acetyltransferase (NAT) activity and liver protoporphyrin level in experimental porphyria.
    Watanabe M; Irifune H; Ohgami T; Nonaka S
    J Dermatol; 1996 Apr; 23(4):238-42. PubMed ID: 8935337
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Comparative histological and electron microscopy study of porphyria cutanea tarda and erythropoietic protoporphyria].
    Kint A
    Verh K Acad Geneeskd Belg; 1978; 40(3):184-225. PubMed ID: 726618
    [No Abstract]   [Full Text] [Related]  

  • 20. Protoporphyrin hepatopathy. Effects of cholic acid ingestion in murine griseofulvin-induced protoporphyria.
    Poh-Fitzpatrick MB; Sklar JA; Goldsman C; Lefkowitch JH
    J Clin Invest; 1983 Oct; 72(4):1449-58. PubMed ID: 6630515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.